In this randomized clinical trial, a low-cost digital intervention increased expectation to adopt health behaviors among adults using glucagon-like peptide-1 receptor agonists (GLP-1RAs), with effects ...

Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescriptions increased from 2018 to 2025, while MBS use decreased beginning in ...

Researchers found that GLP-1 receptor agonist initiation was associated with a reduced risk for disorders related to alcohol, cannabis, cocaine, nicotine, and opioid use. HealthDay News — The use of ...

Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...

GLP-1 receptor agonist use was linked to a significantly higher risk for osteoporosis, gout, and osteomalacia over 5 years.

By Pooja Toshniwal Paharia A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising connection between metabolic ...

GLP-1 receptor agonists used to treat type 2 diabetes and obesity could help reduce risk of addiction to substances like cannabis, alcohol, and cocaine. | Cannabis Sciences ...

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of medications known as GLP-1 receptor agonists.

Two-thirds of patients using weight loss drugs hide their treatment from loved ones, amid rising social stigma. Read more.

The study will include around 200 participants aged 65 or older with BMI of at least 35 starting semaglutide therapy.